GGrantIndex
Sort

21,453 grants matching tuberculosis

Molecular Analysis of Tuberculosis Immunity

$1,760,691
William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2011 · AI

ADULT AIDS CLINICAL TRIALS UNIT

$1,759,926
University Of California San Francisco · U01 · FY2003 · AI

INTERNATIONAL CLINICAL STUDIES SUPPORT CENTER

$1,758,085
Family Health International · N01 · FY2000 · AI

Host Defense Against HIV-related Pulmonary Infections

$1,757,567
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2012 · HL

ADULT AIDS CLINICAL TRIALS UNIT

$1,757,447
University Of Minnesota Twin Cities · U01 · FY2003 · AI

Molecular Analysis of Tuberculosis Immunity

$1,757,043
William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2014 · AI

Molecular Analysis of Tuberculosis Immunity

$1,757,042
William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2012 · AI

Development of a second generation MDR-XDR TB assay

$1,754,517
David Alland · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2011 · AI

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)

$1,754,217
Chad J Achenbach · Northwestern University · U54 · FY2023 · EB

TUBERCULOSIS CONTROL AND ELIMINATION IN THE CITY OF CHICAGO

$1,753,116
Joshua Jones · Chicago Department Of Public Health · U52 · FY2012 · PS

ADULT AIDS CLINICAL TRIALS UNIT

$1,752,570
Case Western Reserve University · U01 · FY2000 · AI

IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

$1,751,169
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Harmonist: A Scalable Toolkit for Standardizing and Coordinating Data Sharing Across International Research Networks

$1,750,128
Stephany Norah Duda · Vanderbilt University Medical Center · R24 · FY2021 · AI

Building Tuberculosis Clinical Research Capacity in China

$1,749,943
Leidos Biomedical Research, Inc. · N01 · FY2012 · CA

Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses

$1,748,997
Beth C Levine · Washington University · U19 · FY2017 · AI

Resolving the bottleneck in antibiotic discovery

$1,748,006
Kim Lewis · Northeastern University · P01 · FY2017 · AI

Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet)

$1,747,727
Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2020 · AI

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.

$1,747,343
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2022 · AI

TIM family of genes: Role in T cell immunity and tolerance

$1,746,368
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2017 · AI

M tuberculosis Membrane Protein Pharmaceutical Targets

$1,742,862
Timothy A Cross · Florida State University · P01 · FY2012 · AI

UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT

$1,741,573
University Of Alabama At Birmingham · U01 · FY2001 · AI

RP4: Harnessing autophagy to treat tuberculosis

$1,740,727
Michael Shiloh · Ut Southwestern Medical Center · U19 · FY2020 · AI

Resolving the bottleneck in antibiotic discovery

$1,738,405
Kim Lewis · Northeastern University · P01 · FY2018 · AI

Enhancing ATG-dependent Defense Against Pathogens w/Therapeutics Lead CP

$1,737,873
Stuart L Schreiber · Washington University · U19 · FY2017 · AI

M tuberculosis Membrane Protein Pharmaceutical Targets

$1,737,687
Timothy A Cross · Florida State University · P01 · FY2011 · AI